This article is
- freely available
Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
University of Western Sydney Clinic and Research Centre Blacktown, Western Sydney Local Health District, Blacktown 2148, NSW, Australia
* Author to whom correspondence should be addressed.
Received: 24 August 2012; in revised form: 21 September 2012 / Accepted: 21 September 2012 / Published: 1 October 2012
Abstract: Thousands of samples for pharmacogenetic tests have been analysed in our laboratory since its establishment. In this article we describe some of the most interesting cases of CYP poor metabolisers associated with adverse reactions to psychotropic drugs. Prevention of disease/illness, including Adverse Drug Reaction (ADR), is an aim of modern medicine. Scientific data supports the fact that evaluation of drug toxicology includes several factors, one of which is genetic variations in pharmacodynamics and pharmacokinetics of drug pathways. These variations are only a part of toxicity evaluation, however, even if it would help to prevent only a small percentage of patients from suffering adverse drug reactions, especially life threatening ADRs, pharmacogenetic testing should play a significant role in any modern psychopharmacologic practice. Medical practitioners should also consider the use of other medications or alternative dosing strategies for drugs in patients identified as altered metabolisers. This will promise not only better and safer treatments for patients, but also potentially lowering overall healthcare costs.
Keywords: venlafaxine; nortriptyline; suicide; adverse effects; genetic polymorphisms; cytochrome P450; pharmacogenetics
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Piatkov, I.; Jones, T.; McLean, M. Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics. J. Pers. Med. 2012, 2, 149-157.
Piatkov I, Jones T, McLean M. Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics. Journal of Personalized Medicine. 2012; 2(4):149-157.
Piatkov, Irina; Jones, Trudi; McLean, Mark. 2012. "Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics." J. Pers. Med. 2, no. 4: 149-157.